Clare Market Investments LLC Invests $343,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Clare Market Investments LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 2,595 shares of the financial services provider’s stock, valued at approximately $343,000.

A number of other hedge funds have also added to or reduced their stakes in the business. Independent Advisor Alliance acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $6,769,000. Sound View Wealth Advisors Group LLC boosted its position in iShares Biotechnology ETF by 5.2% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 6,797 shares of the financial services provider’s stock valued at $899,000 after purchasing an additional 335 shares during the last quarter. Larson Financial Group LLC boosted its position in iShares Biotechnology ETF by 6.2% during the fourth quarter. Larson Financial Group LLC now owns 1,753 shares of the financial services provider’s stock valued at $232,000 after purchasing an additional 102 shares during the last quarter. Generali Investments CEE investicni spolecnost a.s. bought a new position in iShares Biotechnology ETF in the fourth quarter valued at approximately $11,370,000. Finally, Marco Investment Management LLC increased its position in shares of iShares Biotechnology ETF by 16.7% during the 4th quarter. Marco Investment Management LLC now owns 4,886 shares of the financial services provider’s stock worth $646,000 after purchasing an additional 700 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.8 %

Shares of iShares Biotechnology ETF stock opened at $135.84 on Tuesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The business’s 50 day moving average is $136.08 and its 200-day moving average is $140.22. The stock has a market cap of $6.42 billion, a P/E ratio of 24.52 and a beta of 0.84.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.